Darkpulse, INC 10-Q quarterly reports

DarkPulse, Inc. reported a significant decrease in Q1 2026 revenue, primarily due to lower contributions from its Optilan India subsidiary, while facing ongoing liquidity concerns and legal battles.

DarkPulse, Inc. reported a significant reduction in net loss and a substantial increase in revenue for the nine months ended September 30, 2025, primarily driven by recent acquisitions, despite ongoing liquidity challenges and ineffective internal controls.

DarkPulse, Inc. reported a reduced net loss for the six months ended June 30, 2025, driven by significant revenue growth from recent acquisitions, despite ongoing liquidity concerns and a substantial accumulated deficit.

DarkPulse, Inc.'s Q1 2025 shows revenue growth driven by Optilan India, but the company still faces significant financial challenges and going concern uncertainty.

DarkPulse Inc. has filed an amendment to its Q3 2024 report, citing material weaknesses in disclosure controls and ongoing financial concerns, including a significant net loss and going concern uncertainty.

DarkPulse Inc.'s Q3 2024 results reveal a net loss and ongoing financial challenges, including the impact of a subsidiary liquidation and various legal proceedings.

DarkPulse Inc. reports a net loss of $2.95 million for the second quarter of 2024, impacted by the deconsolidation of Optilan UK and ongoing legal proceedings.

DarkPulse Inc. reported a net loss of $536,398 for the first quarter of 2024, impacted by the deconsolidation of a major subsidiary and ongoing legal battles.